Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations

Background: Nucleoside reverse transcriptase inhibitors (NRTIs) and non-NRTIs (NNRTIs) with boosted protease inhibitors are included in standardized first-line and second-line regimens. Recent World Health Organization (WHO) guidelines recommend a boosted protease inhibitor (PI) combined with 2 NRTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yinqiu, Huang, Xiaojie, Luo, Yadong, Zhou, Yihong, Tao, Xingbao, Chen, Hui, Song, Aixin, Chen, Yaokai, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107847/
https://www.ncbi.nlm.nih.gov/pubmed/30174599
http://dx.doi.org/10.3389/fphar.2018.00890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107847/
https://www.ncbi.nlm.nih.gov/pubmed/30174599
http://dx.doi.org/10.3389/fphar.2018.00890

Ejemplares similares